The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Foot and Mouth Disease (FMD) Vaccine Market Research Report 2025
Synopsis
Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
The global Foot and Mouth Disease (FMD) Vaccine market was valued at US$ 1046 million in 2023 and is anticipated to reach US$ 1346.8 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.
Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.
In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.
This report aims to provide a comprehensive presentation of the global market for Foot and Mouth Disease (FMD) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Foot and Mouth Disease (FMD) Vaccine.
Report Scope
The Foot and Mouth Disease (FMD) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Foot and Mouth Disease (FMD) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Foot and Mouth Disease (FMD) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agrovet market
Biogenesis Bago
Vecol
FGBI - Federal Centre for Animal Health
Indian Immunologicals
Merial
VSVRI
FMD Center
Limor de Colombia
Segment by Type
Conventional Vaccines
Emergency Vaccines
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Foot and Mouth Disease (FMD) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Foot and Mouth Disease (FMD) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
The global Foot and Mouth Disease (FMD) Vaccine market was valued at US$ 1046 million in 2023 and is anticipated to reach US$ 1346.8 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.
Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.
In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.
This report aims to provide a comprehensive presentation of the global market for Foot and Mouth Disease (FMD) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Foot and Mouth Disease (FMD) Vaccine.
Report Scope
The Foot and Mouth Disease (FMD) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Foot and Mouth Disease (FMD) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Foot and Mouth Disease (FMD) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agrovet market
Biogenesis Bago
Vecol
FGBI - Federal Centre for Animal Health
Indian Immunologicals
Merial
VSVRI
FMD Center
Limor de Colombia
Segment by Type
Conventional Vaccines
Emergency Vaccines
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Foot and Mouth Disease (FMD) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Foot and Mouth Disease (FMD) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Foot and Mouth Disease (FMD) Vaccine Market Overview
1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccine
1.2 Foot and Mouth Disease (FMD) Vaccine Segment by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Conventional Vaccines
1.2.3 Emergency Vaccines
1.3 Foot and Mouth Disease (FMD) Vaccine Segment by Application
1.3.1 Global Foot and Mouth Disease (FMD) Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Foot and Mouth Disease (FMD) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue 2019-2030
1.4.2 Global Foot and Mouth Disease (FMD) Vaccine Sales 2019-2030
1.4.3 Global Foot and Mouth Disease (FMD) Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Foot and Mouth Disease (FMD) Vaccine Market Competition by Manufacturers
2.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Foot and Mouth Disease (FMD) Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Foot and Mouth Disease (FMD) Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccine, Product Type & Application
2.7 Foot and Mouth Disease (FMD) Vaccine Market Competitive Situation and Trends
2.7.1 Foot and Mouth Disease (FMD) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Foot and Mouth Disease (FMD) Vaccine Players Market Share by Revenue
2.7.3 Global Foot and Mouth Disease (FMD) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Foot and Mouth Disease (FMD) Vaccine Retrospective Market Scenario by Region
3.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Foot and Mouth Disease (FMD) Vaccine Global Foot and Mouth Disease (FMD) Vaccine Sales by Region: 2019-2030
3.2.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Region: 2019-2024
3.2.2 Global Foot and Mouth Disease (FMD) Vaccine Sales by Region: 2025-2030
3.3 Global Foot and Mouth Disease (FMD) Vaccine Global Foot and Mouth Disease (FMD) Vaccine Revenue by Region: 2019-2030
3.3.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Region: 2019-2024
3.3.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Region: 2025-2030
3.4 North America Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.4.1 North America Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2019-2030)
3.4.3 North America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.5.1 Europe Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Foot and Mouth Disease (FMD) Vaccine Sales by Country (2019-2030)
3.5.3 Europe Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.7.1 Latin America Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Type (2019-2030)
4.1.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Type (2019-2024)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccine Sales by Type (2025-2030)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Type (2019-2030)
4.2.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Type (2019-2024)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Type (2025-2030)
4.2.3 Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Foot and Mouth Disease (FMD) Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Application (2019-2030)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Application (2019-2024)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccine Sales by Application (2025-2030)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Application (2019-2030)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Application (2019-2024)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Application (2025-2030)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Foot and Mouth Disease (FMD) Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Agrovet market
6.1.1 Agrovet market Corporation Information
6.1.2 Agrovet market Description and Business Overview
6.1.3 Agrovet market Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Agrovet market Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.1.5 Agrovet market Recent Developments/Updates
6.2 Biogenesis Bago
6.2.1 Biogenesis Bago Corporation Information
6.2.2 Biogenesis Bago Description and Business Overview
6.2.3 Biogenesis Bago Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biogenesis Bago Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.2.5 Biogenesis Bago Recent Developments/Updates
6.3 Vecol
6.3.1 Vecol Corporation Information
6.3.2 Vecol Description and Business Overview
6.3.3 Vecol Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Vecol Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.3.5 Vecol Recent Developments/Updates
6.4 FGBI - Federal Centre for Animal Health
6.4.1 FGBI - Federal Centre for Animal Health Corporation Information
6.4.2 FGBI - Federal Centre for Animal Health Description and Business Overview
6.4.3 FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.4.5 FGBI - Federal Centre for Animal Health Recent Developments/Updates
6.5 Indian Immunologicals
6.5.1 Indian Immunologicals Corporation Information
6.5.2 Indian Immunologicals Description and Business Overview
6.5.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.5.5 Indian Immunologicals Recent Developments/Updates
6.6 Merial
6.6.1 Merial Corporation Information
6.6.2 Merial Description and Business Overview
6.6.3 Merial Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merial Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.6.5 Merial Recent Developments/Updates
6.7 VSVRI
6.6.1 VSVRI Corporation Information
6.6.2 VSVRI Description and Business Overview
6.6.3 VSVRI Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 VSVRI Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.7.5 VSVRI Recent Developments/Updates
6.8 FMD Center
6.8.1 FMD Center Corporation Information
6.8.2 FMD Center Description and Business Overview
6.8.3 FMD Center Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 FMD Center Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.8.5 FMD Center Recent Developments/Updates
6.9 Limor de Colombia
6.9.1 Limor de Colombia Corporation Information
6.9.2 Limor de Colombia Description and Business Overview
6.9.3 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.9.5 Limor de Colombia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Foot and Mouth Disease (FMD) Vaccine Industry Chain Analysis
7.2 Foot and Mouth Disease (FMD) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Foot and Mouth Disease (FMD) Vaccine Production Mode & Process
7.4 Foot and Mouth Disease (FMD) Vaccine Sales and Marketing
7.4.1 Foot and Mouth Disease (FMD) Vaccine Sales Channels
7.4.2 Foot and Mouth Disease (FMD) Vaccine Distributors
7.5 Foot and Mouth Disease (FMD) Vaccine Customers
8 Foot and Mouth Disease (FMD) Vaccine Market Dynamics
8.1 Foot and Mouth Disease (FMD) Vaccine Industry Trends
8.2 Foot and Mouth Disease (FMD) Vaccine Market Drivers
8.3 Foot and Mouth Disease (FMD) Vaccine Market Challenges
8.4 Foot and Mouth Disease (FMD) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
